☰

Empresas y finanzas

BIO-Europe Spring(TM) Receives Unanimous Endorsement of Spanish Bio-Pharma Industry


    EBD Group today announced that registrations for BIO-Europe Spring
    2008, April 7-9, 2008 in Palacio Municipal de Congresos, Madrid,
    Spain, are up 30 percent from last year´s highly successful inaugural
    event in Milan, Italy.

    In addition, BIO-Europe Spring has received the unanimous backing
    of the Spanish Bio-Pharma Industry, including Almirall, Esteve, Grupo
    Uriach, Cellerix and the backing of local hosts of Madrid Biocluster,
    PromoMadrid, IMADE, Camara de Madrid, Genoma Espana, Interes,
    Fundacion para el Conocimiento madri+d and CEIM.

    "The companies and research activities based around Madrid form
    the heart of Spain´s emerging biotechnology industry. Today, Madrid
    leads Spain with 27 percent of total biotech companies and,
    significantly, accounts for 45.2 percent of sales and 45.5 per cent of
    employment by biotech companies. PromoMadrid is very excited to be the
    host of the BIO-Europe Spring 2008 event, which will help illuminate
    the rapid progress of our industry, the undisputed quality of our
    science and the great potential for partnering with Spanish biotechs,"
    said Jesus Sainz, Chairman of PromoMadrid.

    Overall, the number of biotech firms in Spain has doubled in the
    last six years to 150, half of which are focused on product discovery
    and development. There are over 500 enterprises in Spain that are
    engaged in the biotech arena, producing a turnover in excess of EUR
    20,000 Million.

    "The prosperity of the Spanish biotech industry requires forming
    collaborations with firms from around the world and educating the
    biotech industry on the many benefits of forming alliances with
    world-class companies and research institutions in Spain," said Dr.
    Josep Lamarca, Senior Director of Corporate Development Licensing
    Projects, Almirall. "As one of the largest stand-alone partnering
    conferences, BIO-Europe Spring in Madrid will enable the biotech
    industry elite to fully appreciate the deal-making potential in Spain,
    as well as engage with potential collaborators from across the
    biotechnology spectrum."

    BIO-Europe Spring utilizes partneringONE(TM), the industry´s most
    trusted and intuitive web-based conference partnering system that is
    purpose-built to create and facilitate connections among companies
    across entire global industry value-chains.

    "We look forward to a highly productive and exciting conference in
    Madrid," said Carola Schropp, EBD Group´s managing director. "The
    success of BIO-Europe Spring among key pharma-biotech players is the
    powerful mix of "virtual" online collaboration with a stimulating
    physical event. Partnering in all its complexity, whether based on
    product licensing or a technology transfer, whether for a merger or
    acquisition, the process must start with a contact and targeting the
    right partners at the right time."

    Notes to Editors:

    Entry to BIO-Europe Spring 2008 is free to the media, including
    full access to the partnering system, sessions, press conferences,
    workshops, and pre-arranged partnering meetings. Visit the BIO-Europe
    Spring conference website at http://www.ebdgroup.com/bes/press_reg.htm
    for detailed information on this year´s conference and online
    registration. When you register online, please indicate in the comment
    field that you are requesting a complimentary press registration.
    Please fax a copy of your press pass to complete your complimentary
    media registration to fax number +49 (89) 23 88 756 55.

    About BIO-Europe Spring 2008

    The BIO-Europe Spring(TM) event brings together international
    decision-makers from all sectors of the biotechnology industry, and
    features the successful combination of one-to-one meetings, company
    presentations, panel discussions and a lively exhibition.

    Positioned as the springtime counterpart to EBD Group´s flagship
    conference, BIO-Europe, the BIO-Europe Spring event continues the
    tradition of providing life science companies with high calibre
    partnering opportunities. The event enables biotechnology companies to
    identify, meet and network with companies across the biotechnology
    value-chain from large biotech and pharma companies to financiers and
    innovative start-ups.

    About EBD Group

    EBD Group is the leading partnering firm for the global
    biotechnology industry. Since 1993, firms in the life sciences have
    leveraged EBD Group´s partnering conferences, technology and services
    to identify business opportunities and develop strategic relationships
    that drive their business. EBD Group´s conferences (run in
    collaboration with leading industry partners and international trade
    associations) include BIO-Europe, the world´s largest stand-alone life
    science partnering conference (co-organized with BIO); BIO-Europe
    Spring(R); and BioEquity Europe (co-organized with BioCentury
    Publications and BIO). EBD´s novel, web-based, partnering service
    partneringONE(TM) is also used at numerous third-party events around
    the world. Outside of the conference format, EBD Group´s consultants
    can provide hands-on assistance for firms seeking to in- or
    out-license products and technologies. EBD Group has offices in San
    Diego and London.

    For more information visit www.ebdgroup.com